Search Results - Jochen G Mainz

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lava... by Nina Erdmann, Theresa Schilling, Julia Hentschel, Thomas Lehmann, Philipp von Bismarck, Tobias Ankermann, Franziska Duckstein, Michael Baier, Carlos Zagoya, Jochen G. Mainz, Jochen G. Mainz, Jochen G. Mainz

    Published in Frontiers in Immunology (2022-11-01)
    Get full text
    Article


  2. 2

    Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR... by Patience N. Eschenhagen, Patience N. Eschenhagen, Patience N. Eschenhagen, Petra Bacher, Petra Bacher, Claudia Grehn, Jochen G. Mainz, Jochen G. Mainz, Alexander Scheffold, Carsten Schwarz, Carsten Schwarz, Carsten Schwarz

    Published in Frontiers in Pharmacology (2023-06-01)
    Get full text
    Article


  3. 3

    Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies by Marina A. Stefano, Rosana E. Poderoso, Jochen G. Mainz, Jose D. Ribeiro, Antonio F. Ribeiro, Elizete Aparecida Lomazi

    Get full text
    Article


  4. 4

    Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score by Jochen G. Mainz, Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Daniel Peckham, Carsten Schwarz

    Published in Frontiers in Pharmacology (2022-06-01)
    Get full text
    Article


  5. 5

    Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score by Jochen G. Mainz, Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Daniel Peckham, Carsten Schwarz

    Published in Frontiers in Pharmacology (2023-05-01)
    Get full text
    Article


  6. 6

    Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic Fibrosis by Cristina Zubiria-Barrera, Malena Bos, Robert Neubert, Jenny Fiebig, Michael Lorenz, Michael Hartmann, Jochen G. Mainz, Hortense Slevogt, Tilman E. Klassert

    Published in Journal of Fungi (2025-08-01)
    Get full text
    Article


  7. 7

    Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts by Jochen G. Mainz, Andrea Gerber, Michael Lorenz, Ruth Michl, Julia Hentschel, Anika Nader, James F. Beck, Mathias W. Pletz, Andreas H. Mueller

    Published in Case Reports in Infectious Diseases (2015-01-01)
    Get full text
    Article


  8. 8

    Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients’ Upper and Lower Airways after IV-Antibiotic Therapy by Ulrike Müller, Julia Hentschel, Wibke K. Janhsen, Kerstin Hünniger, Uta-Christina Hipler, Jürgen Sonnemann, Wolfgang Pfister, Klas Böer, Thomas Lehmann, Jochen G. Mainz

    Published in Mediators of Inflammation (2015-01-01)
    Get full text
    Article


  9. 9

    Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire by Jochen G. Mainz, Jochen G. Mainz, Anton Barucha, Anton Barucha, Pu Huang, Pu Huang, Lilith Bechinger, Lilith Bechinger, Franziska Duckstein, Franziska Duckstein, Louise Polte, Louise Polte, Pauline Sadrieh, Pauline Sadrieh, Lutz Nährlich, Olaf Eickmeier, Suzanne Van Dullemen, Patience Eschenhagen, Carsten Schwarz, Stefan Lüth, Carlos Zagoya, Carlos Zagoya, Ute Graepler-Mainka

    Published in Frontiers in Pharmacology (2023-10-01)
    Get full text
    Article


  10. 10

    Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis by Flávia N.S. Infante, Elizete A. Lomazi, Carlos Zagoya, Franziska Duckstein, Daniela O. Magro, Fernando Pessotto, Antônio F. Ribeiro, José D. Ribeiro, Jochen G. Mainz

    Published in Jornal de Pediatria (2025-01-01)
    Get full text
    Article


  11. 11

    Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy by Barry J Plant, Daniel Peckham, Pierre-Régis Burgel, Alan Smyth, Andreas Jung, Manfred Ballmann, Giovanni Taccetti, Harry Heijerman, Pavel Drevinek, Jochen G Mainz, Carsten Schwarz

    Published in BMJ Open Respiratory Research (2024-07-01)
    Get full text
    Article


  12. 12

    Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings. by Harold Tabori, Christin Arnold, Anke Jaudszus, Hans-Joachim Mentzel, Diane M Renz, Steffen Reinsch, Michael Lorenz, Ruth Michl, Andrea Gerber, Thomas Lehmann, Jochen G Mainz

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


  13. 13

    A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study. [version 2; peer review:... by Christabella Ng, Helen Barr, Caroline Hoad, Neele S Dellschaft, Robin Spiller, Luca Marciani, Alan R Smyth, Trevor Hill, Colin Crooks, Jochen G Mainz, Alex Menys, Giles Major, Penny A. Gowland

    Published in NIHR Open Research (2024-03-01)
    Get full text
    Article


  14. 14

    Antigen specificity and cross-reactivity drive functionally diverse anti–Aspergillus fumigatus T cell responses in cystic fibrosis by Carsten Schwarz, Patience Eschenhagen, Henrijette Schmidt, Thordis Hohnstein, Christina Iwert, Claudia Grehn, Jobst Roehmel, Eva Steinke, Mirjam Stahl, Laura Lozza, Ekaterina Tikhonova, Elisa Rosati, Ulrik Stervbo, Nina Babel, Jochen G. Mainz, Hilmar Wisplinghoff, Frank Ebel, Lei-Jie Jia, Matthew G. Blango, Peter Hortschansky, Sascha Brunke, Bernhard Hube, Axel A. Brakhage, Olaf Kniemeyer, Alexander Scheffold, Petra Bacher

    Published in The Journal of Clinical Investigation (2023-03-01)
    Get full text
    Article


  15. 15

    Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus. by Sibylle Junge, Dennis Görlich, Martijn den Reijer, Bärbel Wiedemann, Burkhard Tümmler, Helmut Ellemunter, Angelika Dübbers, Peter Küster, Manfred Ballmann, Cordula Koerner-Rettberg, Jörg Große-Onnebrink, Eberhardt Heuer, Wolfgang Sextro, Jochen G Mainz, Jutta Hammermann, Joachim Riethmüller, Ute Graepler-Mainka, Doris Staab, Bettina Wollschläger, Rüdiger Szczepanski, Antje Schuster, Friedrich-Karl Tegtmeyer, Sivagurunathan Sutharsan, Alexandra Wald, Jerzy-Roch Nofer, Willem van Wamel, Karsten Becker, Georg Peters, Barbara C Kahl

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


Search Tools: